The National Advertising Division found that Freshpet's dog food advertisements were misleading, specifically claims that their product is made 'the same way you make healthy food for people,' implying human-grade quality. Following this ruling on March 17, 2026, Freshpet's stock declined nearly 11%, dropping $7.95 per share from $75.37 to $67.42. A securities litigation law firm is now investigating potential federal securities law violations on behalf of affected investors.

Pomerantz LLP is investigating potential securities fraud claims against Freshpet, Inc. following a BBB National Programs ruling that found certain dog food claims unsupported, particularly regarding 'human grade' labeling. The company agreed to comply with the recommendation, but the announcement triggered a 10.55% stock price decline on March 17, 2026.

The BBB National Programs' National Advertising Division found that Freshpet's dog food advertisements were misleading, specifically claims that their product is made 'the same way you make healthy food for people,' implying human-grade quality. Following this ruling on March 17, 2026, Freshpet's stock declined nearly 11% from $75.37 to $67.42 per share. A securities litigation law firm is investigating potential federal securities law violations on behalf of affected investors.

The National Advertising Division ruled on a challenge by The Farmer's Dog against Freshpet's advertising claims. While some claims were supported, NAD recommended that Freshpet discontinue claims suggesting its dog food is "human grade," particularly in social media advertisements. Freshpet agreed to comply with the recommendations.

Freshpet announced the appointment of John O'Connor as Chief Financial Officer (effective February 9, 2026) and Ana Lopez as Senior Vice President of Supply Chain (effective February 2, 2026). O'Connor succeeds Ivan Garcia, who transitions to Senior Vice President of Finance. The company reaffirmed its full year 2025 outlook and will report Q4 and full year 2025 results on February 23, 2026.

Chewy is a successful e-commerce pet retailer with over 130,000 products, but the article advises caution before investing. While the company showed 8.3% year-over-year revenue growth in Q3 2025 with improving profit margins, structural challenges persist. With net profit margins around 2% and the entire pet industry characterized by low margins, Chewy's growth prospects appear limited. The author recommends staying on the sidelines until profitability improves and valuation drops.

Technical analysis suggests Freshpet stock may experience further decline to around $30 before potential long-term recovery, based on Elliott Wave analysis of its price movements.

Despite a generally positive market in 2025, several technology, entertainment, and food-related stocks have experienced significant value declines. The article analyzes five companies that have lost over 50% of their value and suggests potential for recovery.

The article discusses three stocks - Target, Celsius Holdings, and Freshpet - that have seen significant declines over the past year but may have the potential to bounce back. It provides an analysis of the challenges and opportunities for each company.

Freshpet's stock closed nearly 3% lower after an analyst at Piper Sandler reduced his price target on the company, citing slowing revenue growth due to softened spending by lower- and middle-income customers. However, the analyst maintained an overweight (buy) recommendation, noting that higher-income consumers continue to spend on the company's fresh, healthy pet food products.

Freshpet stock declined nearly 11% this week after an analyst downgraded the company's recommendation and two others cut their price targets, citing management's more subdued outlook and disappointing guidance.

JP Morgan analyst Ken Goldman cut Freshpet's price target from $154 to $102, citing concerns over changing consumption trends and uncertainty about consensus estimates. The analyst revised revenue and EBITDA estimates lower for FY25/26 and introduced weaker FY27 growth and EBITDA forecasts.